Implementation of AI-driven 3D-printed guidance improves outcomes in cervical cancer with parametrial invasion, suggesting better treatment quality.
AI/3D-printed applicator-guided BT for cervical cancer with parametrial invasion demonstrated successful implementation, significant dosimetric benefits to organs at risk (OARs) and better plan quality indicators (CI, HI, and OI), and minimal treatment-related complications. This method represents a promising advancement in BT for cervical cancer treatment.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: